These data indicate that to a variable extent, in all cancer cells there is a putative net conversion of serine to glycine, catalyzed either by the cytosolic or mitochondrial serine hydroxymethyl transferase (SHMT1 and SHMT2, respectively). Here, SHMT1 is linked to cancer.